REG - Dialight PLC - Issue of Equity and Total Voting Rights

DialightAnnouncement

Mon 10:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260316:nRSP7999Wa&default-theme=true

RNS Number : 7999W  Dialight PLC  16 March 2026

16 March 2026

 

Dialight plc (the "Company")

Issue of Equity and Total Voting Rights

The Company announces that the Board has approved the allotment of 201,027 new
ordinary shares of 1.89 pence each in the capital of the Company (the "New
Ordinary Shares") in connection with the vesting of awards granted in 2023
under the Dialight Performance Share Plan.

Application has been made for the New Ordinary Shares to be admitted to
trading on the equity shares (commercial companies) category of the Official
List of the Financial Conduct Authority and to trading on the London Stock
Exchange's Main Market for listed securities. Admission is expected to become
effective on 18 March 2026.

The New Ordinary Shares will rank pari passu in all respects with the existing
ordinary shares of the Company.

Following Admission, the Company's issued share capital will comprise
40,406,483 ordinary shares of 1.89 pence each, none of which are held in
treasury. Accordingly, the total number of voting rights in the Company will
be 40,406,483. This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in the Company, under the
FCA's Disclosure and Transparency Rules.

Enquiries:

Dialight plc

Laura Walker

Company Secretary

+44 (0)203 058 3525

LEI: 2138001AD31KKD29Z495

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEAKABNKBKDCND



            Copyright 2019 Regulatory News Service, all rights reserved